New combo therapy shows promise for hard-to-treat thyroid cancer

This study tested whether combining targeted drugs (trametinib and dabrafenib) with radioactive iodine can help shrink or control advanced thyroid cancer that has stopped responding to standard radioactive iodine treatment. The trial enrolled 40 adults with specific gene mutations (RAS or BRAFV600E). The goal was to see how many patients had their tumors shrink significantly or disappear completely.